9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Hoffmann-La Roche
M.D. Anderson Cancer Center
University of Southern California
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Pfizer
Sensei Biotherapeutics, Inc.
Baylor College of Medicine
OncoC4, Inc.
Tempus AI
Cybrexa Therapeutics
Shanghai PerHum Therapeutics Co., Ltd.